Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (12)

    1. Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults 2026-10-01 · Expand citations
    2. A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults 2026-09-21 · Expand citations
    3. Evaluating psilocybin for the management of depression: a literature review 2026-08-02 · Expand citations
    4. Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development 2026-07-03 · Expand citations
    5. Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA 2026-06-15 · Expand citations
    6. Beyond prohibition: A public health analysis of naturalistic psychedelic use 2025-07-03 · Expand citations
    7. University Students’ Motives for Psilocybin Use: A Mixed-Methods Analysis 2025-04-26 · Expand citations
    8. Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms 2024-09-09 · Expand citations
    9. Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare 2024-06-28 · Expand citations
    10. Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin 2023-10-12 · Expand citations
    11. Psilocybin-based mushrooms and usage 2023-04-30 · Expand citations
    12. Psilocybin as a healer 2022-09-12 · Expand citations